B-type natriuretic peptide is not a volume marker among patients on hemodialysis

Nephrology Dialysis Transplantation

Volumn 28, Issue 12, 2013, Pages 3082-3089

  Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BNP; Dry weight; ESRD; Hemodialysis; Hypertension

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VOLUME; CONTROLLED STUDY; DISEASE MARKER; DRY WEIGHT; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPERVOLEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION; YOUNG ADULT;

BNP; DRY WEIGHT; ESRD; HEMODIALYSIS; HYPERTENSION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE MONITORING, AMBULATORY; BLOOD VOLUME; BODY WEIGHT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RENAL DIALYSIS; YOUNG ADULT;

EID: 84880919258     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft054     Document Type: Article

References (27)

1. Sinha AD, Agarwal R. Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status. Semin Dial 2009; 22: 480-482
2. Sinha AD. Why assistive technology is needed for probing of dry weight. Blood Purif 2011; 31: 197-202
3. Kuhlmann MK, Zhu F, Seibert E et al. Bioimpedance, dry weight and blood pressure control: new methods and consequences. Curr Opin Nephrol Hypertens 2005; 14: 543-549
4. Lopot F, Kotyk P, Blaha J et al. Use of continuous blood volume monitoring to detect inadequately high dry weight. Int J Artif Organs 1996; 19: 411-414
5. Sinha AD, Light RP, Agarwal R. Relative plasma volume monitoring during hemodialysis aids the assessment of dry weight. Hypertension 2010; 55: 305-311
6. Cheriex EC, Leunissen KM, Janssen JH et al. Echography of the inferior vena cava is a simple and reliable tool for estimation of 'dry weight' in haemodialysis patients. Nephrol Dial Transplant 1989; 4: 563-568
7. Satyan S, Light RP, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 2007; 50: 1009-1019
8. Leunissen KM, Menheere PP, Cheriex EC et al. Plasma alphahuman atrial natriuretic peptide and volume status in chronic haemodialysis patients. Nephrol Dial Transplant 1989; 4: 382-386
9. Lauster F, Gerzer R, Weil J et al. Assessment of dry body-weight in haemodialysis patients by the biochemical marker cGMP. Nephrol Dial Transplant 1990; 5: 356-361
10. Lauster F, Fulle HJ, Gerzer R et al. The postdialytic plasma cyclic guanosine 30,50-monophosphate level as a measure of fluid overload in chronic hemodialysis. J Am Soc Nephrol 1992; 2: 1451-1454
11. Kouw PM, Kooman JP, Cheriex EC et al. Assessment of postdialysis dry weight: a comparison of techniques. J Am Soc Nephrol 1993; 4: 98-104
12. Mallamaci F, Zoccali C, Tripepi G et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 2001; 59: 1559-1566
13. Zoccali C, Mallamaci F, Benedetto FA et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-1515
14. Fagugli RM, Palumbo B, Ricciardi D et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract 2003; 95: c60-c66
15. Lee SW, Song JH, Kim GA et al. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 2003; 41: 1257-1266
16. Sheen V, Bhalla V, Tulua-Tata A et al. The use of B-type natriuretic peptide to assess volume status in patients with endstage renal disease. Am Heart J 2007; 153: 244-245
17. David S, Kumpers P, Seidler V et al. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. Nephrol Dial Transplant 2008; 23: 1370-1377
18. Booth J, Pinney J, Davenport A. N-terminal proBNP-marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 2010; 5: 1036-1040
19. Ishizaka Y, Yamamoto Y, Fukunaga T et al. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis 1994; 24: 461-472
20. Das SR, Drazner MH, Dries DL et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005; 112: 2163-2168
21. Wang TJ, Larson MG, Levy D et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594-600
22. Agarwal R, Alborzi P, Satyan S et al. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009; 53: 500-507
23. Charra B, Laurent G, Chazot C et al. Clinical assessment of dry weight. Nephrol Dial Transplant 1996; 11: 16-19
24. Jaeger JQ, Mehta RL. Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 1999; 10: 392-403
25. Holden JE, Kelley K, Agarwal R. Analyzing change: a primer on multilevel models with applications to nephrology. Am J Nephrol 2008; 28: 792-801
26. Chen CH, Lin YP, Yu WC et al. Volume status and blood pressure during long-term hemodialysis: role of ventricular stiffness. Hypertension 2003; 42: 257-262
27. Joffy S, Rosner MH. Natriuretic peptides in ESRD. Am J Kidney Dis 2005; 46: 1-10